CoreCap Advisors’s BioNTech BNTX Stock Holding History

CoreCap Advisors’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.82K	Hold	84	–	–	﹤0.01%	2156
2026 Q1	$7.47K	Hold	84	–	–	﹤0.01%	2058
2025 Q4	$8K	Hold	84	–	–	﹤0.01%	2044
2025 Q3	$8.28K	Hold	84	–	–	﹤0.01%	2015
2025 Q2	$8.94K	Hold	84	–	–	﹤0.01%	1914
2025 Q1	$7.65K	Sell	84 -100	-54%	-$11.2K	﹤0.01%	1933
2024 Q4	$21K	Buy	184 +129	+235%	+$14.7K	﹤0.01%	1520
2024 Q3	$6.53K	Hold	55	–	–	﹤0.01%	1911
2024 Q2	$4.42K	Hold	55	–	–	﹤0.01%	1192
2024 Q1	$5.07K	Buy	+55	New	+$5.27K	﹤0.01%	1912
2022 Q4	$6.52K	Buy	+43	New	+$6.62K	﹤0.01%	1670
2022 Q3	–	Sell	-43	Closed	-$6K	–	717
2022 Q2	$6K	Buy	+43	New	+$6.57K	﹤0.01%	1601
2022 Q1	–	Sell	-201	Closed	-$52K	–	730
2021 Q4	$52K	Buy	+201	New	+$55K	﹤0.01%	982

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

CoreCap Advisors's BNTX Position: Q2 2026 in Review

CoreCap Advisors held its BioNTech (BNTX) position steady in Q2 2026 at 84 shares worth $7.82K. The position accounts for ﹤0.01% of the portfolio, ranked #2156.

CoreCap Advisors first reported a position in BNTX in Q4 2021 and has held it in 13 quarters since. The position peaked at $52K in Q4 2021. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

CoreCap Advisors held 84 shares of BioNTech worth $7.82K as of Q2 2026.
CoreCap Advisors left its BioNTech share count unchanged in Q2 2026.
BioNTech made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #2156 holding.
CoreCap Advisors first reported a position in BioNTech in Q4 2021 and has held it in 13 quarters since.
CoreCap Advisors's BioNTech position peaked at $52K in Q4 2021.
283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.